EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Electronic cigarette use during pregnancy and the risk of adverse birth outcomes: A cross-sectional surveillance study of the US Pregnancy Risk Assessment Monitoring System (PRAMS) population

Lin Ammar iD, Hilary A Tindle, Angela M Miller, Margaret A Adgent, Hui Nian, Kelli K Ryckman iD, Mulubrhan Mogos, Mariann R Piano, Ethan Xie, Brittney M Snyder, Abhismitha Ramesh iD, Chang Yu und 2 weitere

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0287348 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift PLOS ONE, 2023. Verfasst von Lin Ammar und 13 weiteren Autor:innen. Beteiligte Einrichtung: Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America. Hauptthemen laut MEDLINE: Premature Birth, Electronic Nicotine Delivery Systems, Vaping. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NICHD NIH HHS, NIDA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Research on health effects and potential harms of electronic cigarette (EC) use during pregnancy is limited. We sought to determine the risks of pregnancy EC use on pregnancy-related adverse birth outcomes and assess whether quitting ECs reduces the risks.

Methods

Women with singleton live births who participated in the US Pregnancy Risk Assessment Monitoring System (PRAMS) survey study 2016–2020 were classified into four mutually exclusive groups, by their use of ECs and combustible cigarettes (CCs) during pregnancy: non-use, EC only use, CC only use, and dual use. We determined the risk of preterm birth, low birth weight, and small-for-gestational-age (SGA) by comparing cigarette users to non-users with a modified Poisson regression model adjusting for covariates. In a subset of women who all used ECs prior to pregnancy, we determined whether quitting EC use reduces the risk of preterm birth, low birth weight, and SGA by comparing to those who continued its use. All analyses were weighted to account for the PRAMS survey design and non-response rate.

Results

Of the 190,707 women (weighted N = 10,202,413) included, 92.1% reported cigarette non-use, 0.5% EC only use, 6.7% CC only use, and 0.7% dual use during pregnancy. Compared with non-use, EC only use was associated with a significantly increased risk of preterm birth (adjusted risk ratio [aRR]: 1.29, 95% confidence interval [CI]: 1.00, 1.65) and low birth weight (aRR: 1.38, 95%CI: 1.09, 1.75), but not SGA (aRR: 1.04, 95%CI: 0.76, 1.44). Among 7,877 (weighted N = 422,533) women EC users, quitting use was associated with a significantly reduced risk of low birth weight (aRR: 0.76, 95%CI: 0.62, 0.94) and SGA (aRR: 0.77, 95%CI: 0.62, 0.94) compared to those who continued to use ECs during pregnancy.

Conclusions

Pregnancy EC use, by itself or dual use with CC, is associated with preterm birth and low birth weight. Quitting use reduces that risk. ECs should not be considered as a safe alternative nor a viable gestational smoking cessation strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Premature BirthElectronic Nicotine Delivery SystemsVapingPregnancyInfant, NewbornHumansFemaleCross-Sectional StudiesRisk AssessmentArrhythmias, CardiacFetal Growth Retardation

Autor:innen und Institutionen

  • Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
  • The Vanderbilt Center for Tobacco, Addiction and Lifestyle, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
  • Geriatric Research Education and Clinical Centers, Veterans Affairs Tennessee Valley Healthcare System, Nashville, Tennessee, United States of America.
  • Division of Population Health Assessment, Tennessee Department of Health, Nashville, Tennessee, United States of America.
  • Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.

ORCID-Profile: Lin Ammar, Kelli K Ryckman, Abhismitha Ramesh, Tina V Hartert, Pingsheng Wu

Förderung

  • NHLBI NIH HHS
  • NICHD NIH HHS
  • NIDA NIH HHS
  • NCATS NIH HHS
  • National Institute on Drug Abuse
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • National Heart, Lung, and Blood Institute
  • National Center for Advancing Translational Sciences

Zitieren

APA

Ammar, L., Tindle, H. A., Miller, A. M., Adgent, M. A., Nian, H., Ryckman, K. K., Mogos, M., Piano, M. R., Xie, E., Snyder, B. M., Ramesh, A., Yu, C., Hartert, T. V., & Wu, P. (2023). Electronic cigarette use during pregnancy and the risk of adverse birth outcomes: A cross-sectional surveillance study of the US Pregnancy Risk Assessment Monitoring System (PRAMS) population. PLOS ONE. https://doi.org/10.1371/journal.pone.0287348

Vancouver

Ammar L, Tindle HA, Miller AM, Adgent MA, Nian H, Ryckman KK, et al. Electronic cigarette use during pregnancy and the risk of adverse birth outcomes: A cross-sectional surveillance study of the US Pregnancy Risk Assessment Monitoring System (PRAMS) population. PLOS ONE. 2023. doi:10.1371/journal.pone.0287348

BibTeX
@article{Ammar2023,
  author = {Ammar, Lin and Tindle, Hilary A and Miller, Angela M and Adgent, Margaret A and Nian, Hui and Ryckman, Kelli K and Mogos, Mulubrhan and Piano, Mariann R and Xie, Ethan and Snyder, Brittney M and Ramesh, Abhismitha and Yu, Chang and Hartert, Tina V and Wu, Pingsheng},
  title = {Electronic cigarette use during pregnancy and the risk of adverse birth outcomes: A cross-sectional surveillance study of the US Pregnancy Risk Assessment Monitoring System (PRAMS) population},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0287348}
}
Kostenlos starten →